RIO DE JANEIRO, BRAZIL - The Butantan Institute has received less active pharmaceutical ingredient (API) than agreed with the Asian pharmaceutical company, which in a meeting with diplomats complained about Brazil's stance.
Sinovac laboratory executives urged the government of Jair Bolsonaro to stop criticizing China to ensure compliance with contracts for coronavirus vaccines, according to Brazilian diplomats.
The cables sent by the Brazilian Embassy in Beijing, submitted to the Parliamentary Investigation Committee (CPI) on the government's management of the pandemic, reported on a meeting between Brazilian diplomats and top officials of the Sinovac laboratory, who voiced their rejection of . . .